Literature DB >> 7373307

Changes in neostriatal dopamine concentrations in response to levodopa infusions.

H J Doller, J D Connor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373307     DOI: 10.1111/j.1471-4159.1980.tb09969.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  7 in total

1.  Pharmacokinetics and effects of levodopa in advanced Parkinson's disease.

Authors:  E Bredberg; J Tedroff; S M Aquilonius; L Paalzow
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Preservation of function in Parkinson's disease: what's learning got to do with it?

Authors:  Jeff A Beeler
Journal:  Brain Res       Date:  2011-09-29       Impact factor: 3.252

3.  The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease.

Authors:  N Turjanski; W Fernandez; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-07       Impact factor: 10.154

4.  Changes in electroretinogram and serum potassium during L-DOPA treatment in parkinsonism.

Authors:  D Terziivanov; M Filipova; I Janků; J Balík; V Filip; L Stika
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983

5.  Age influences magnitude but not duration of response to levodopa.

Authors:  R Durso; K Isaac; L Perry; M Saint-Hilaire; R G Feldman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

6.  Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson's disease.

Authors:  Bradley J Robottom
Journal:  Patient Prefer Adherence       Date:  2011-01-20       Impact factor: 2.711

Review 7.  Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Authors:  Dag Nyholm
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 5.577

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.